David N. Haylock

6.9k total citations · 2 hit papers
80 papers, 5.4k citations indexed

About

David N. Haylock is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, David N. Haylock has authored 80 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 22 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in David N. Haylock's work include Hematopoietic Stem Cell Transplantation (33 papers), Mesenchymal stem cell research (12 papers) and Platelet Disorders and Treatments (12 papers). David N. Haylock is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Mesenchymal stem cell research (12 papers) and Platelet Disorders and Treatments (12 papers). David N. Haylock collaborates with scholars based in Australia, United States and Germany. David N. Haylock's co-authors include Susan K. Nilsson, Paul J. Simmons, Brenda Williams, Mark J. Styles, Raffaele Riccò, Stephen Mudie, Kang Liang, Cara M. Doherty, Stephen G. Bell and Anita J. Hill and has published in prestigious journals such as Nature Communications, Blood and Immunity.

In The Last Decade

David N. Haylock

79 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules

2015 1.2k citations Kang Liang, Raffaele Riccò et al. Nature Communications profile →
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells

2005 577 citations Susan K. Nilsson, Genevieve Whitty et al. Blood profile →

Peers

Countries citing papers authored by David N. Haylock

Since Specialization

Citations

This map shows the geographic impact of David N. Haylock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Haylock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Haylock more than expected).

Fields of papers citing papers by David N. Haylock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Haylock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Haylock. The network helps show where David N. Haylock may publish in the future.

Co-authorship network of co-authors of David N. Haylock

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Haylock. A scholar is included among the top collaborators of David N. Haylock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Haylock. David N. Haylock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microfluidic Devices for Manufacture of Therapeutic Extracellular Vesicles: Advances and Opportunities 2025 ·Journal of Extracellular Vesicles ·Amin Hassanzadeh‐Barforoushi, (unknown), Ella L. Johnston, David N. Haylock, Yuling Wang	6
2	Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules breakdown → 2015 ·Nature Communications ·Kang Liang, Raffaele Riccò, Cara M. Doherty, Mark J. Styles, Stephen G. Bell, Nigel Kirby, Stephen Mudie, David N. Haylock, Anita J. Hill, Christian J. Doonan, Paolo Falcaro	1245
3	Predictions for optimal mitigation of paracrine inhibitory signalling in haemopoietic stem cell cultures 2015 ·Stem Cell Research & Therapy ·Joseph D. Berry, (unknown), Petar Liovic, David N. Haylock	8
4	FOXN1GFP/w Reporter hESCs Enable Identification of Integrin-β4, HLA-DR, and EpCAM as Markers of Human PSC-Derived FOXN1+ Thymic Epithelial Progenitors 2014 ·Stem Cell Reports ·Chew-Li Soh, (unknown), (unknown), David A. Elliott, Tanya Hatzistavrou, Suzanne J. Micallef, (unknown), Natalie Seach, Juan Carlos Zúñiga‐Pflücker, Ann P. Chidgey, Alan Trounson, Susan K. Nilsson, David N. Haylock, Richard L. Boyd, Andrew G. Elefanty, Edouard G. Stanley	32
5	Biomanufacture of human platelets for transfusion: Rationale and approaches 2014 ·Experimental Hematology ·(unknown), (unknown), David N. Haylock	23
6	Potent Agonists of a Hematopoietic Stem Cell Cytokine Receptor, c‐Mpl 2013 ·ChemMedChem ·(unknown), David N. Haylock, Laurence Meagher, (unknown), John White, Susan K. Nilsson, Jéssica Andrade, Kellie Cartledge, David A. Winkler	5
7	Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential 2010 ·Blood ·Jochen Grassinger, David N. Haylock, Brenda Williams, (unknown), Susan K. Nilsson	82
8	Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media 2010 ·Biomaterials ·Andrew B.J. Prowse, Michael R. Doran, Justin J. Cooper‐White, (unknown), Trent P. Munro, Jane Fitzpatrick, (unknown), David N. Haylock, Peter P. Gray, Ernst J. Wolvetang	77
9	The Use of Experimental Murine Models to Assess Novel Agents of Hematopoietic Stem and Progenitor Cell Mobilization 2008 ·Biology of Blood and Marrow Transplantation ·Kirsten Herbert, Jean-Pierre Lévesque, David N. Haylock, Miles Prince	8
10	Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues 2007 ·Blood ·(unknown), (unknown), Rebecca Driessen, Genevieve Whitty, David N. Haylock, Ivan Bertoncello, A. Ian Smith, Bruno Péault, Manuela Tavian, Paul J. Simmons	91
11	Transcriptional analysis of early lineage commitment in human embryonic stem cells 2007 ·BMC Developmental Biology ·Andrew L. Laslett, Sean M. Grimmond, Brooke Gardiner, Lincon A. Stamp, (unknown), Susan M. Hawes, Sam Wormald, David J. Nikolic‐Paterson, David N. Haylock, Martín F. Pera	70
12	Stage specific gene expression of serpins and their cognate proteases during myeloid differentiation 2006 ·British Journal of Haematology ·(unknown), David N. Haylock, Genevieve Whitty, Robert L. Medcalf, Paul Coughlin	10
13	Rôle des intégrines et sélectines dans le développement et les régulations du système hématopoïétique 2001 ·Hématologie ·Jean-Pierre Lévesque, Yasushi Takamatsu, Susan K. Nilsson, David N. Haylock, Paul J. Simmons	1
14	Mucin‐like Molecules as Modulators of the Survival and Proliferation of Primitive Hematopoietic Cells 2001 ·Annals of the New York Academy of Sciences ·Paul J. Simmons, Jean-Pierre Lévesque, David N. Haylock	24
15	Comparison of three methods of CD34+ cell enumeration in peripheral blood: Dual-platform ISHAGE protocol versus single-platform, versus microvolume fluorimetry 2000 ·Cytotherapy ·(unknown), H. Miles Prince, Dominic Wall, (unknown), David N. Haylock, Michael Quinn, (unknown), Deon J. Venter	12
16	Ex Vivo Culture of Peripheral Blood CD34+ Cells: Effects of Hematopoietic Growth Factors on Production of Neutrophilic Precursors 1997 ·Journal of Hematotherapy ·Shigeyoshi Makino, David N. Haylock, (unknown), (unknown), Silvana Niutta, L.B. To, Christopher A. Juttner, PJ Simmons	16
17	Detection of minimal residual disease in an AML patient with trisomy 8 using interphase FISH 1997 ·Pathology ·Deborah L. White, Cheryl Hutchins, (unknown), Jeffrey C. Suttle, David N. Haylock, Timothy P. Hughes, Christopher A. Juttner, L. Bik To	7
18	Hollow-fibre affinity cell separation system for CD34+ cell enrichment 1996 ·Cytometry ·Robert Nordon, David N. Haylock, (unknown), Klaus Schindhelm	11
19	Ex Vivo Hematopoietic Progenitor Cell Expansion 1994 ·PubMed ·David N. Haylock, Shigeyoshi Makino, (unknown), (unknown), Silvana Niutta, L.B. To, CA Juttner, Paul J. Simmons	9
20	A discrepancy between the instantaneous and the overall collection efficiency of the fenwal CS3000 for peripheral blood stem cell apheresis 1992 ·Journal of Clinical Apheresis ·David N. Haylock, (unknown), D Thorp, (unknown), Christopher A. Juttner, (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact